To validate the credibility of using commercially available blood-based serological assays for tear film analysis as a COVID-19 diagnostic, we studied the relationship between the levels of anti-SARS-CoV-2 IgA antibodies in tears and in blood in the early phase of infection. This evidence concerns the gene CD79A and infection.